Correction: Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting (Journal of Gastroenterology, (2024), 10.1007/s00535-024-02186-9)
the Japan Oncology Network in Hepatobiliary and Pancreas
研究成果: ジャーナルへの寄稿 › コメント/討論